Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Autor:
Christoph Münch, Thomas Meyer, Laura Steinfurth, Teresa Holm, André Maier, Robert Meyer, Paul Wicks, P. Linke
Publikováno v:
Amyotrophic Lateral Sclerosis
Self-assessment of symptom progression in chronic diseases is of increasing importance in clinical research, patient management and specialized outpatient care. Against this background, we developed a secure internet platform (ALShome.de) that allows
Autor:
Richard J. Kryscio, Megan Malley Thompson, Maria S Malguizo, Marta S. Mendiondo, Als Nutrition, Margaret Healey, Edward J. Kasarskis, Stephen Wells
Publikováno v:
Amyotrophic Lateral Sclerosis. 12:17-25
Our objective was to investigate the nutritional requirements in ALS and to determine the feasibility of early intervention with NIPPV. Subjects were enrolled into one of two arms. In the nutrition arm, total daily energy expenditure (TDEE) was deter
Publikováno v:
Amyotrophic Lateral Sclerosis. :1-8
In the past two decades new practice parameters for clinical care in ALS were developed and several clinical trials were performed. We sought to review information in these prospective datasets and assess whether natural history of ALS has changed ov
Autor:
Adriano Chiò, Giancarlo Logroscino, Orla Hardiman, Robert Swingler, Douglas Mitchell, Ettore Beghi, Bryan G. Traynor, null On Behalf of the Eurals Consortium
Publikováno v:
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, Taylor & Francis, 2009, 10 (5-6), pp.310-23. ⟨10.3109/17482960802566824⟩
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, Taylor & Francis, 2009, 10 (5-6), pp.310-23. ⟨10.3109/17482960802566824⟩
International audience; We have performed a systematic review to summarize current knowledge concerning factors related to survival in ALS and to evaluate the implications of these data for clinical trials design. The median survival time from onset
Publikováno v:
Amyotrophic Lateral Sclerosis. :1-6
Improving quality of life (QoL) is a major goal in ALS palliative care. Previous studies performed on the general ALS population showed no relationship between QoL and disease progression. ALS subjects participating in clinical trials may differ from
Publikováno v:
Amyotrophic Lateral Sclerosis. 9:195-211
Free radical accumulation and oxidative stress have been proposed as contributing to the progression of amyotrophic lateral sclerosis (motor neuron disease). A range of antioxidant medications is available, and has been studied. We aimed to examine t
Publikováno v:
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, Taylor & Francis, 2012, 13 (6), pp.599-601. ⟨10.3109/17482968.2012.711835⟩
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, Taylor & Francis, 2012, 13 (6), pp.599-601. ⟨10.3109/17482968.2012.711835⟩
International audience; The aim of this study was to examine the coping strategies of 49 patients with amyotrophic lateral sclerosis (ALS) and the potential impact of these strategies on survival. A total of 49 subjects were recruited. Each subject w